| 前收市價 | 1.6300 |
| 開市 | 1.9600 |
| 買盤 | 1.4000 |
| 賣出價 | 3.0000 |
| 拍板 | 5.00 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 1.6300 - 1.9600 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 54 |
Insider MonkeyFate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript May 11, 2024 Fate Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call [Operator Instructions]. This call is […]
ZacksFate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksFate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
